相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Co-Mutation of FAT3 and LRP1B in Lung Adenocarcinoma Defines a Unique Subset Correlated With the Efficacy of Immunotherapy
Mingyu Zhu et al.
FRONTIERS IN IMMUNOLOGY (2022)
Glucose metabolism characteristics and TLR8-mediated metabolic control of CD4+ Treg cells in ovarian cancer cells microenvironment
Rui Xu et al.
CELL DEATH & DISEASE (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
IgA transcytosis and antigen recognition govern ovarian cancer immunity
Subir Biswas et al.
NATURE (2021)
Seeing the forest for the trees-single-cell atlases link CD8+ T cells andmacrophages to disease progression and treatment response in kidney cancer
Mei Yee Koh et al.
CANCER CELL (2021)
Application of a classifier combining bronchial transcriptomics and chest computed tomography features facilitates the diagnostic evaluation of lung cancer in smokers and nonsmokers
Yang Xia et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39)
Kathleen N. Moore et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Identification of a Prognostic Signature for Ovarian Cancer Based on the Microenvironment Genes
Xiao Huo et al.
FRONTIERS IN GENETICS (2021)
The Overexpression of Acyl-CoA Medium-Chain Synthetase-3 (ACSM3) Suppresses the Ovarian Cancer Progression via the Inhibition of Integrin β1/AKT Signaling Pathway
Limei Yan et al.
FRONTIERS IN ONCOLOGY (2021)
Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study
Eric Pujade-Lauraine et al.
LANCET ONCOLOGY (2021)
COL11A1 activates cancer-associated fibroblasts by modulating TGF-β3 through the NF-κB/IGFBP2 axis in ovarian cancer cells
Yi-Hui Wu et al.
ONCOGENE (2021)
Extracellular matrix protein-1 secretory isoform promotes ovarian cancer through increasing alternative mRNA splicing and stemness
Huijing Yin et al.
NATURE COMMUNICATIONS (2021)
Comprehensive Landscape of Ovarian Cancer Immune Microenvironment Based on Integrated Multi-Omics Analysis
Jiacheng Shen et al.
FRONTIERS IN ONCOLOGY (2021)
Association of Copy Number Variation Signature and Survival in Patients With Serous Ovarian Cancer
Ryon P. Graf et al.
JAMA NETWORK OPEN (2021)
Characterizing the tumor microenvironment of metastatic ovarian cancer by single-cell transcriptomics
Susan Olalekan et al.
CELL REPORTS (2021)
Tumor-infiltrating lymphocytes in the immunotherapy era
Sterre T. Paijens et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
Homologous Recombination Repair Deficiency and the Immune Response in Breast Cancer: A Literature Review
B. Pellegrino et al.
TRANSLATIONAL ONCOLOGY (2020)
Tumour immune cell infiltration and survival after platinum-based chemotherapy in high-grade serous ovarian cancer subtypes: A gene expression-based computational study
Rong Liu et al.
EBIOMEDICINE (2020)
Characteristics of Tumor-Infiltrating Lymphocytes Prior to and During Immune Checkpoint Inhibitor Therapy
Ioana Plesca et al.
FRONTIERS IN IMMUNOLOGY (2020)
Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer
Shirish Gadgeel et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Role of M1-polarized tumor-associated macrophages in the prognosis of advanced ovarian cancer patients
Antonio Maccio et al.
SCIENTIFIC REPORTS (2020)
Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised, open-label, phase 3 study
Jing Huang et al.
LANCET ONCOLOGY (2020)
M2 Macrophages Infiltrating Epithelial Ovarian Cancer Express MDR1: A Feature That May Account for the Poor Prognosis
Susann Badmann et al.
CELLS (2020)
Effect of macrophages on biological function of ovarian cancer cells in tumor microenvironment in vitro
Yi Jiang et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2020)
Integrated Analysis of Prognostic and Immune Associated Integrin Family in Ovarian Cancer
Anqi Wu et al.
FRONTIERS IN GENETICS (2020)
Clinical outcomes of prexasertib monotherapy in recurrent BRCA wild-type high-grade serous ovarian cancer involve innate and adaptive immune responses
Erika J. Lampert et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Salvage Ipilimumab and Nivolumab in Patients With Metastatic Renal Cell Carcinoma After Prior Immune Checkpoint Inhibitors
Anita Gul et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Upregulation of mesothelial genes in ovarian carcinoma cells is associated with an unfavorable clinical outcome and the promotion of cancer cell adhesion
Kaire Ojasalu et al.
MOLECULAR ONCOLOGY (2020)
The Roles of Integrin α5β1 in Human Cancer
Jianbing Hou et al.
ONCOTARGETS AND THERAPY (2020)
Development and Validation of an Immune-Related Prognostic Signature for Ovarian Cancer Based on Weighted Gene Coexpression Network Analysis
Yuanyuan An et al.
BIOMED RESEARCH INTERNATIONAL (2020)
Changes in the Tumor Immune Microenvironment during Disease Progression in Patients with Ovarian Cancer
Marie Christine Wulff Westergaard et al.
CANCERS (2020)
Current progress in the inflammatory background of angiogenesis in gynecological cancers
Grzegorz Szewczyk et al.
INFLAMMATION RESEARCH (2019)
Genomic correlates of response to immune checkpoint blockade
Tanya E. Keenan et al.
NATURE MEDICINE (2019)
Immune Cell Types and Secreted Factors Contributing to Inflammation-to-Cancer Transition and Immune Therapy Response
Xingwei Chen et al.
CELL REPORTS (2019)
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
Yingyao Zhou et al.
NATURE COMMUNICATIONS (2019)
Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian Carcinoma
Panagiotis A. Konstantinopoulos et al.
JAMA ONCOLOGY (2019)
Pembrolizumab in patients with programmed death ligand 1-positive advanced ovarian cancer: Analysis of KEYNOTE-028
Andrea Varga et al.
GYNECOLOGIC ONCOLOGY (2019)
Prognostic value of neutrophil-to-lymphocyte ratio in early-stage ovarian clear-cell carcinoma
Kosuke Yoshida et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2019)
Pro-inflammatory M1 macrophage enhances metastatic potential of ovarian cancer cells through NF-B activation
Untack Cho et al.
MOLECULAR CARCINOGENESIS (2018)
Changes in ovarian cancer survival during the 20 years before the era of targeted therapy
Jung-Yun Lee et al.
BMC CANCER (2018)
Myeloid-derived suppressor cells coming of age
Filippo Veglia et al.
NATURE IMMUNOLOGY (2018)
Tumor Hypoxia As an Enhancer of Inflammation-Mediated Metastasis: Emerging Therapeutic Strategies
Josh W. DiGiacomo et al.
TARGETED ONCOLOGY (2018)
Prognostic value of preoperative lymphocyte-monocyte ratio in patients with ovarian clear cell carcinoma
Byung Su Kwon et al.
JOURNAL OF CANCER (2018)
Patient inflammatory status and CD4+/CD8+intraepithelial tumor lymphocyte infiltration are predictors of outcomes in high-grade serous
Mauricio P. Pinto et al.
GYNECOLOGIC ONCOLOGY (2018)
Tumor-infiltrating T cells in epithelial ovarian cancer: predictors of prognosis and biological basis of immunotherapy
Weimin Wang et al.
GYNECOLOGIC ONCOLOGY (2018)
Maftools: efficient and comprehensive analysis of somatic variants in cancer
Anand Mayakonda et al.
GENOME RESEARCH (2018)
Integrated Genomic, Epigenomic, and Expression Analyses of Ovarian Cancer Cell Lines
Eniko Papp et al.
CELL REPORTS (2018)
Genomics of response to immune checkpoint therapies for cancer: implications for precision medicine
Jake R. Conway et al.
GENOME MEDICINE (2018)
A Strong B-cell Response Is Part of the Immune Landscape in Human High-Grade Serous Ovarian Metastases
Anne Montfort et al.
CLINICAL CANCER RESEARCH (2017)
T-cell target antigens across major gynecologic cancers
Alba Rodriguez-Garcia et al.
GYNECOLOGIC ONCOLOGY (2017)
Prognostic value of programmed death-ligand 1 (PD-L1) expression in ovarian clear cell carcinoma
Jun Zhu et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2017)
Prognostic significance and predictors of the system inflammation score in ovarian clear cell carcinoma
Hongwei Zhang et al.
PLOS ONE (2017)
DNA Damage and Repair Biomarkers of Immunotherapy Response
Kent W. Mouw et al.
CANCER DISCOVERY (2017)
Osteopontin is involved in TLR4 pathway contributing to ovarian cancer cell proliferation and metastasis
Cong Xu et al.
ONCOTARGET (2017)
Proteome and Acetylome Analysis Identifies Novel Pathways and Targets Regulated by Perifosine in Neuroblastoma
Xiao Gu et al.
SCIENTIFIC REPORTS (2017)
Immunosuppressive cells in tumor immune escape and metastasis
Yang Liu et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2016)
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
Etienne Becht et al.
GENOME BIOLOGY (2016)
Safety and Antitumor Activity of Anti-PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer
Junzo Hamanishi et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma
Richard A. Moffitt et al.
NATURE GENETICS (2015)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
Homologous Recombination Deficiency: Exploiting the Fundamental Vulnerability of Ovarian Cancer
Panagiotis A. Konstantinopoulos et al.
CANCER DISCOVERY (2015)
Functional role of G9a histone methyltransferase in cancer
Francesco Casciello et al.
FRONTIERS IN IMMUNOLOGY (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Immune Microenvironment in Tumor Progression: Characteristics and Challenges for Therapy
Valerie Chew et al.
JOURNAL OF ONCOLOGY (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
IL-10 immunomodulation of myeloid cells regulates a murine model of ovarian cancer
Kevin M. Hart et al.
FRONTIERS IN IMMUNOLOGY (2011)
A flexible R package for nonnegative matrix factorization
Renaud Gaujoux et al.
BMC BIOINFORMATICS (2010)
Macrophages, innate immunity and cancer: balance, tolerance, and diversity
Alberto Mantovani et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
affy -: analysis of Affymetrix GeneChip data at the probe level
L Gautier et al.
BIOINFORMATICS (2004)
Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer
L Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
分享论文
